David H. Au, MD, MS

Associate Professor
Division of Pulmonary and Critical Care Medicine

Education and Training

BA in Biology, University of Chicago, Chicago, IL 1989

MD, University of Chicago-Pritzker School of Medicine, Chicago, IL 1993

Internship and Residency in Internal Medicine, University Hospitals of Cleveland, Cleveland, OH 1996

MS in Epidemiology, University of Washington, Seattle, WA 1999

Fellowship in Health Services Research and Development, VA Puget Sound Health Care System, Seattle, WA 2001

Fellowship in Pulmonary and Critical Care Medicine, University of Washington, Seattle, WA 2001

Research Interests

My primary research focuses on improving the quality and delivery of care for patients with chronic lung diseases.  In particular, I am interested in primary pulmonary manifestations of tobacco smoke; COPD and more recently lung cancer.   My focus has been to examine the process and delivery of care, promote communication between patients and providers as well as examine the effects of pharmaceutical therapies on both pulmonary and non-pulmonary outcomes.

Representative Publications

Au DH, Bryson CL, Fan VS, Curtis JR, Udris EM, McDonell MB, Fihn SD. Beta-Blockers as Single Agent Therapy for Hypertension and the Risk of Mortality among Patients with Chronic Obstructive Pulmonary Disease. Am J Med. 2004 Dec 15;117(12):925-31

Au DH, Udris EM, Fihn SD, McDonell MB, Curtis JR.  Differences in Health Care Utilization at the End-of-Life among patients with COPD and patients with lung cancer.  Archives of Int Med 2006 Feb 13;166(3):326-31.

Parimon T, Au DH, Martin P, Chien JW. Pretransplant Assessment of Mortality Risk after Allogeneic Hematopoietic Cell Transplantation.  Ann Int. Med. 2006 Feb 13;166(3):326-31.

Parimon T, Chien JW, Bryson CL, McDonell MB, Udris EM, Au DH, Inhaled Corticosteroids and Risk of Lung Cancer among Patients with COPD.  Am J Resp Crit Care Med (In press)

top of page